AlternativeMed
ancient wisdom Β· Remedy

Zi Long Jin Tablet; Zilongjin Tablet

Zi Long Jin Tablet; Zilongjin Tablet. Chinese patent medicines. For: Used for chemotherapy of primary lung cancer with deficiency of both qi and blood, symptoms and symptoms are fatigue, lack of qi, lazy speech, dizziness, loss of appetite, shortness of breath, sp

πŸ“œ Names
Pinyin Name
Zilongjin Pian
中文名 (Chinese)
紫龙金片
English Name
Zi Long Jin Tablet; Zilongjin Tablet
πŸ’Š Form & Use
Category
Chinese patent medicines
Dosage Form
片剂 (Tablet)
Administration
Oral
Source / 出倄
Chinese Pharmacopoeia 2020 edition
🌿 Composition β€” Clickable herb chips
🩺 Syndromes & Indications
Syndromes (δΈ­ζ–‡)
η›Šζ°”ε…»θ‘€οΌŒζΈ…ηƒ­θ§£ζ―’οΌŒη†ζ°”εŒ–η˜€
Indications (δΈ­ζ–‡)
η”¨δΊŽζ°”θ‘€δΈ€θ™šθ―εŽŸε‘ζ€§θ‚Ίη™ŒεŒ–η–—θ€…οΌŒη—‡θ§η₯žη–²δΉεŠ›γ€ε°‘ζ°”ζ‡’θ¨€γ€ε€΄ζ˜ηœΌθŠ±γ€ι£Ÿζ¬²δΈζŒ―γ€ζ°”ηŸ­θ‡ͺ汗、咳嗽、疼痛
Indications (English)
Used for chemotherapy of primary lung cancer with deficiency of both qi and blood, symptoms and symptoms are fatigue, lack of qi, lazy speech, dizziness, loss of appetite, shortness of breath, spontaneous sweating, cough, pain
0
Clinical Trials
2
Meta-Analyses
0
PubMed References
πŸ“‹ Sample Trials
None linked yet.
πŸ“Š Sample Meta-Analyses
CRD42020162177
The Effect of Zilongjin Tablets combined with chemotherapy in the treatment of non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials
In the classification of lung cancer, non-small cell lung cancer (NSCLC) account
CRD42020197499
Zilongjin tablet adjunct with chemotherapy for the treatment of non-small cell lung cancer: A meta-analysis and systematic review
Lung cancer is the foremost cause of cancer-related deaths globally, of which ap
πŸ“š Sample References
None linked yet.
πŸ₯ Indications β€” click any to find related diseases